Numerous clinical studies suggest that tirzepatide may lead to greater weight loss compared to semaglutide
The structural valve failure that causes varicose veins, spider veins, and chronic venous insufficiency does not reverse with weight loss alone, and GLP-1 medications are not a substitute for vein treatment
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet
This ultra-conservative approach adds four extra weeks to the titration timeline but can significantly reduce initial gastrointestinal symptoms, particularly for researchers who have experienced severe nausea with other GLP-1 based peptides
Li X, Song Y, Guo T, Xiao G, Li Q
Tirzepatide (Mounjaro) has produced some of the largest weight-loss results seen with this class in obesity trials [9], though GI side effects can be strong early on